Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Therapie|July 1, 1996
[Essential elements of quality assurance of clinical trials in hospital environment]A Spriet, P Chaumet-RiffaudSurgical Neurology|July 1, 1992
Nicardipine in the prevention of spasm-induced neurological deficits after subarachnoid hemorrhage: a dose-ranging studyH Massiou, P Chaumet-Riffaud, I BourdeixBone|January 1, 1993
Residential care and risk of proximal femur fractureL Miravet, P Chaumet-Riffaud, J RanstamTherapie|May 1, 1993
[Therapeutic trials in Alzheimer disease. Selection--recruitment and stratification]P Chaumet-Riffaud, Y Wolmark, J J Péré, et al.British Journal of Clinical Pharmacology|November 1, 1989
Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseasesJ L Pinquier, S Urien, P Chaumet-Riffaud, et al.The American Journal of Physiology|November 1, 1981
Altered PGE2 and PGF2 alpha production by glomeruli and papilla of sodium-depleted and sodium-loaded ratsP Chaumet-Riffaud, J P Oudinet, J Sraer, et al.British Journal of Clinical Pharmacology|March 12, 1999
A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteersL Tennezé, V Daurat, A Tibi, et al.Pharmacology|January 1, 1988
Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytesJ L Pinquier, S Urien, M Lemaire, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 9, 2008
Hyperosmolarity causes inflammation through the methylation of protein phosphatase 2AM Abolhassani, X Wertz, M Pooya, et al.Journal of Cardiovascular Pharmacology|April 1, 1988
Binding of [3H]isradipine (PN 200-110) on smooth muscle cell membranes from different bovine arteriesJ L Pinquier, S Urien, P Chaumet-Riffaud, et al.Pageof 3